Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126199871 | 12619987 | 1 | I | 20160704 | 20160705 | 20160803 | 20160803 | EXP | CA-ABBVIE-16P-028-1671789-00 | ABBVIE | 42.52 | YR | F | Y | 0.00000 | 20160803 | CN | COUNTRY NOT SPECIFIED | CA |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126199871 | 12619987 | 1 | PS | LUPRON DEPOT | LEUPROLIDE ACETATE | 1 | Intramuscular | Y | UNKNOWN | 19732 | 7.5 | MG | POWDER AND SOLVENT FOR SUSPENSION FOR INJECTION | /month | |||||
126199871 | 12619987 | 2 | C | DIAMOX SEQUELS | ACETAZOLAMIDE | 1 | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126199871 | 12619987 | 1 | Product used for unknown indication |
126199871 | 12619987 | 2 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126199871 | 12619987 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126199871 | 12619987 | Bladder prolapse | |
126199871 | 12619987 | Oophorectomy bilateral | |
126199871 | 12619987 | Uterine leiomyoma |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
126199871 | 12619987 | 1 | 201601 | 20160512 | 0 |